Stock listing
NASDAQ:AARD Aardvark Therapeutics, Inc. Stock
Home listing (NASDAQ) of Aardvark Therapeutics, Inc.
Follow Aardvark Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:AARD
$1.20 USD -0.16 (-11.8%)
Close on Nov 2, 2026
- Day range
- $1.20 – $1.40 USDNov 2, 2026
- Volume
- 337,956 sharesNov 2, 2026
- Market cap
- $26.26M USDAt the close on Nov 2, 2026 · price × 21.88M shares outstanding
- 52-week range
- $0.93 – $16.60 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $1.33M USDMedian day 129,800 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:AARD · Home | $1.20 USD | -0.16 (-11.8%) | 337,956 | $1.37 | $1.396 | $1.20 | $1.36 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:AARD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.20 | -0.16 | -11.8% | $1.37 | $1.396 | $1.20 | 337,956 | |
| $1.36 | -0.08 | -5.6% | $1.39 | $1.46 | $1.33 | 463,800 | |
| $1.44 | -0.07 | -4.6% | $1.48 | $1.53 | $1.362 | 955,900 | |
| $1.51 | +0.21 | +16.2% | $1.22 | $1.59 | $1.176 | 2,019,000 | |
| $1.30 | +0.22 | +20.4% | $1.09 | $1.39 | $1.09 | 4,282,800 | |
| $1.08 | -0.31 | -22.3% | $1.245 | $1.39 | $0.93 | 4,957,700 | |
| $1.39 | -2.56 | -64.8% | $2.99 | $3.00 | $1.39 | 16,346,500 | |
| $3.95 | -0.46 | -10.4% | $4.27 | $4.31 | $3.89 | 1,415,300 | |
| $4.41 | +0.51 | +13.1% | $3.95 | $4.54 | $3.95 | 218,400 | |
| $3.90 | +0.16 | +4.3% | $3.80 | $4.051 | $3.78 | 66,700 | |
| $3.74 | -0.04 | -1.1% | $3.75 | $4.05 | $3.64 | 129,800 | |
| $3.78 | -0.08 | -2.1% | $4.19 | $4.19 | $3.73 | 97,200 | |
| $3.86 | -0.02 | -0.5% | $3.86 | $3.977 | $3.77 | 68,800 | |
| $3.88 | -0.16 | -4.0% | $3.93 | $4.35 | $3.83 | 126,100 | |
| $4.04 | -0.41 | -9.2% | $4.44 | $4.63 | $4.03 | 218,300 | |
| $4.45 | -0.31 | -6.5% | $4.81 | $4.877 | $4.40 | 99,900 | |
| $4.76 | +0.05 | +1.1% | $4.61 | $4.82 | $4.60 | 140,900 | |
| $4.71 | -0.25 | -5.0% | $4.77 | $5.09 | $4.57 | 316,000 | |
| $4.96 | -0.08 | -1.6% | $4.95 | $5.33 | $4.69 | 212,000 | |
| $5.04 | -0.18 | -3.4% | $5.28 | $5.45 | $4.66 | 251,900 | |
| $5.22 | +0.23 | +4.6% | $5.03 | $5.37 | $5.03 | 61,300 | |
| $4.99 | -0.28 | -5.3% | $5.37 | $5.66 | $4.88 | 147,700 | |
| $5.27 | 0.00 | 0.0% | $5.29 | $5.42 | $5.13 | 47,800 | |
| $5.27 | -0.08 | -1.5% | $5.42 | $5.524 | $5.27 | 28,100 | |
| $5.35 | +0.08 | +1.5% | $5.21 | $5.39 | $5.002 | 39,600 | |
| $5.27 | +0.21 | +4.2% | $5.05 | $5.32 | $4.96 | 60,600 | |
| $5.06 | -0.49 | -8.8% | $5.57 | $5.60 | $5.02 | 71,500 | |
| $5.55 | -0.01 | -0.2% | $5.55 | $5.69 | $5.325 | 96,100 | |
| $5.56 | -0.19 | -3.3% | $5.74 | $5.74 | $5.415 | 54,800 | |
| $5.75 | +0.18 | +3.2% | $5.51 | $5.84 | $5.50 | 101,300 | |
| $5.57 | +0.19 | +3.5% | $5.44 | $5.575 | $5.34 | 110,300 | |
| $5.38 | -0.15 | -2.7% | $5.44 | $5.59 | $5.19 | 129,800 | |
| $5.53 | +0.38 | +7.4% | $5.32 | $5.77 | $5.19 | 258,100 | |
| $5.15 | +0.13 | +2.6% | $5.04 | $5.29 | $4.93 | 47,900 | |
| $5.02 | -0.53 | -9.5% | $5.47 | $5.545 | $5.01 | 64,200 | |
| $5.55 | +0.42 | +8.2% | $4.90 | $5.88 | $4.80 | 216,900 | |
| $5.13 | +0.12 | +2.4% | $5.11 | $5.54 | $4.975 | 276,600 | |
| $5.01 | +0.09 | +1.8% | $4.87 | $5.015 | $4.54 | 209,400 | |
| $4.92 | -0.41 | -7.7% | $5.33 | $5.456 | $4.895 | 109,700 | |
| $5.33 | -0.05 | -0.9% | $5.33 | $5.71 | $5.10 | 164,700 | |
| $5.38 | -0.35 | -6.1% | $5.72 | $5.991 | $5.15 | 257,800 | |
| $5.73 | -0.22 | -3.7% | $5.92 | $6.19 | $5.60 | 89,300 | |
| $5.95 | +0.03 | +0.5% | $6.05 | $6.225 | $5.795 | 59,400 | |
| $5.92 | -0.18 | -3.0% | $6.00 | $6.245 | $5.807 | 85,000 | |
| $6.10 | +0.31 | +5.4% | $5.70 | $6.155 | $5.30 | 125,400 | |
| $5.79 | -0.83 | -12.5% | $6.47 | $6.47 | $5.62 | 143,000 | |
| $6.62 | -0.19 | -2.8% | $6.89 | $7.085 | $6.585 | 74,200 | |
| $6.81 | -0.44 | -6.1% | $7.29 | $7.30 | $6.21 | 111,900 | |
| $7.25 | +0.37 | +5.4% | $6.94 | $7.31 | $6.49 | 145,204 | |
| $6.88 | +0.06 | +0.9% | $6.75 | $6.97 | $6.283 | 83,299 | |
| $6.82 | +0.93 | +15.8% | $5.91 | $6.90 | $5.80 | 173,700 | |
| $5.89 | -0.86 | -12.7% | $6.76 | $7.12 | $5.76 | 250,200 | |
| $6.75 | +0.605 | +9.8% | $6.27 | $7.14 | $6.27 | 182,600 | |
| $6.145 | -0.595 | -8.8% | $6.78 | $6.86 | $6.045 | 79,100 | |
| $6.74 | +0.20 | +3.1% | $6.54 | $7.51 | $6.54 | 154,900 | |
| $6.54 | +0.13 | +2.0% | $6.46 | $6.815 | $6.175 | 69,100 | |
| $6.41 | -0.16 | -2.4% | $6.53 | $6.98 | $6.34 | 130,900 | |
| $6.57 | -0.62 | -8.6% | $7.15 | $7.525 | $6.395 | 158,600 | |
| $7.19 | -0.37 | -4.9% | $7.68 | $7.68 | $6.485 | 177,814 | |
| $7.56 | -0.34 | -4.3% | $7.76 | $7.76 | $7.26 | 91,506 | |
| $7.90 | +0.60 | +8.2% | $7.46 | $8.12 | $7.305 | 74,600 | |
| $7.30 | -0.22 | -2.9% | $7.56 | $7.56 | $7.15 | 63,100 | |
| $7.52 | +0.29 | +4.0% | $7.20 | $7.88 | $7.20 | 195,900 | |
| $7.23 | +0.15 | +2.1% | $7.20 | $7.55 | $7.09 | 132,000 | |
| $7.08 | +0.48 | +7.3% | $6.65 | $7.26 | $6.64 | 96,100 |
- Ticker
- NASDAQ:AARD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 23, 2026
Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials
Latest deck · Oct 23, 2026
Technical Presentation (October 2026)
Technical · 26 slides
Latest news
Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials
Oct 23, 2026
Closed $1.39 (-64.8%) on Oct 23, 2026
Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data
Oct 22, 2026
Closed $1.39 (-64.8%) on Oct 23, 2026
Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors
Oct 8, 2026
Closed $4.71 (-5.0%) on Oct 8, 2026
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026
Closed $5.22 (+4.6%) on Oct 5, 2026
Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug 11, 2026
Closed $6.57 (-8.6%) on Aug 12, 2026
Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold
May 14, 2026
Closed $4.57 (-32.1%) on May 15, 2026
Aardvark Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
May 7, 2026
Closed $5.60 (-4.9%) on May 7, 2026
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Mar 23, 2026
Closed $4.07 (-0.1%) on Mar 23, 2026
Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
Feb 27, 2026
Closed $5.47 (-56.2%) on Mar 2, 2026
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 13, 2026
Closed $12.10 (-1.5%) on Feb 13, 2026
Decks
Technical Presentation (October 2026)
Technical · 26 slides · Oct 23, 2026
Investor Presentation (January 2026)
Investor deck · 29 slides · Jan 12, 2026
ObesityWeek Investor Webinar 2025
Conference · 65 slides · Nov 6, 2025
Investor Presentation (September 2025)
Investor deck · 22 slides · Sep 3, 2025
Aardvark Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 32 in all · newest Oct 23, 2026 · oldest 2025
- Decks
- 4 decks · latest Oct 23, 2026
Where Aardvark Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:AARD · Home listing · This page | NASDAQ | United States | USD |
| BOATS:AARD | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Aardvark Therapeutics, Inc.